The clinical decision support systems market is segmented by application into medical diagnosis, alerts and reminders, prescription decision support, information retrieval and other applications.

Decision Support System (DSS): A computer-based tool that integrates models, data, and expert knowledge to assist individuals in analysing decision problems and identifying optimal courses of action.

Objective To evaluate the feasibility, usability and acceptability of implementing a treat-to-target (T2T) strategy supported ...

Researchers compared their long-standing diagnostic decision support systems AI tool, DXplain, with modern large language models like ChatGPT and Gemini, finding DXplain performed slightly better ...

From Rule-Based To Personalized For decades, clinical decision support systems have relied on static, rule-based algorithms.

The global clinical decision support systems market was valued at $4.48 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.4% from 2022 to 2030.

Mass General Brigham researchers see value in a hybrid approach that makes use of generative artificial intelligence to diagnose patients. Comparing two large language models (LLMs) – OpenAI's GPT-4 ...

Contracted support includes GDSS system releases in a non-service-interrupted process that addresses system sustainment, support to fielding and operational maintenance and administrative support to ...

Race-based decision making also has led to disparities in use of hospice care and other end-of-life treatment, particularly among racial and ethnic minority groups. 10 However, race does not ...

The global clinical decision support systems market is set for robust growth, expanding from $3.14 billion in 2024 to $10.74 billion by 2034, fueled by a demand for AI-driven solutions and increasing ...